These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 7913147

  • 1. Pulmonary vascular smooth muscle relaxation by cGMP- versus cAMP-mediated mechanisms.
    Fullerton DA, Hahn AR, Banerjee A, Harken AH.
    J Surg Res; 1994 Aug; 57(2):259-63. PubMed ID: 7913147
    [Abstract] [Full Text] [Related]

  • 2. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
    Truss MC, Uckert S, Stief CG, Kuczyk M, Schulz-Knappe P, Forssmann WG, Jonas U.
    Neurourol Urodyn; 1996 Aug; 15(1):59-70. PubMed ID: 8696357
    [Abstract] [Full Text] [Related]

  • 3. Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation.
    Tsujimoto G, Lee CH, Hoffman BB.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):411-5. PubMed ID: 2430092
    [Abstract] [Full Text] [Related]

  • 4. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.
    Edwards JC, Ignarro LJ, Hyman AL, Kadowitz PJ.
    J Pharmacol Exp Ther; 1984 Jan; 228(1):33-42. PubMed ID: 6319670
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides.
    Traish A, Moreland RB, Huang YH, Kim NN, Berman J, Goldstein I.
    Mol Cell Biol Res Commun; 1999 Aug; 2(2):131-7. PubMed ID: 10542137
    [Abstract] [Full Text] [Related]

  • 7. Magnesium is essential in mechanisms of pulmonary vasomotor control.
    Fullerton DA, Hahn AR, Agrafojo J, Sheridan BC, McIntyre RC.
    J Surg Res; 1996 Jun; 63(1):93-7. PubMed ID: 8661179
    [Abstract] [Full Text] [Related]

  • 8. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R.
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [Abstract] [Full Text] [Related]

  • 9. The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure.
    Toyoshima H, Nasa Y, Kohsaka Y, Isayama Y, Yamaguchi F, Sanbe A, Takeo S.
    Br J Pharmacol; 1998 Jan; 123(2):344-52. PubMed ID: 9489624
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of cyclic nucleotides in renal artery smooth muscle relaxation.
    Karsten AJ, Derouet H, Ziegler M, Eckert RE.
    Urol Res; 2003 Feb; 30(6):367-73. PubMed ID: 12599016
    [Abstract] [Full Text] [Related]

  • 14. Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man.
    Pan HY, Hoffman BB, Pershe RA, Blaschke TF.
    J Pharmacol Exp Ther; 1986 Dec; 239(3):802-7. PubMed ID: 3025419
    [Abstract] [Full Text] [Related]

  • 15. Role of Na(+)-K+ ATPase in cyclic GMP-mediated relaxation of canine pulmonary artery smooth muscle cells.
    Tamaoki J, Tagaya E, Nishimura K, Isono K, Nagai A.
    Br J Pharmacol; 1997 Sep; 122(1):112-6. PubMed ID: 9298536
    [Abstract] [Full Text] [Related]

  • 16. Desensitization of beta-adrenergic receptor-mediated vascular smooth muscle relaxation.
    Tsujimoto G, Hoffman BB.
    Mol Pharmacol; 1985 Feb; 27(2):210-7. PubMed ID: 2578603
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
    Merkel LA, Rivera LM, Perrone MH, Lappe RW.
    Eur J Pharmacol; 1992 May 27; 216(1):29-35. PubMed ID: 1326438
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phosphodiesterase inhibition overcomes pulmonary vasomotor dysfunction in acute lung injury.
    Sheridan BC, McIntyre RC, Meldrum DR, Fullerton DA.
    J Surg Res; 1997 Aug 27; 71(2):145-9. PubMed ID: 9299282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.